Los Angeles Capital Management
INFI

Los Angeles Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Los Angeles Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-49,930
Closed -$67K – 1233
2016
Q4 		$67K Hold
49,930
– – ﹤0.01% 1147
2016
Q3 		$78K Sell
49,930
-1,100
-2% -$1.69K ﹤0.01% 1209
2016
Q2 		$68K Buy
+51,030
New +$239K ﹤0.01% 1220

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Los Angeles Capital Management's INFI Position: Q1 2017 in Review

Los Angeles Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2017, closing a stake of 49,930 shares — an estimated $67K sold.

Los Angeles Capital Management first reported a position in INFI in Q2 2016 and held it in 3 quarters. The position peaked at $78K in Q3 2016. 80 funds tracked by Wall St. Rank hold INFI as of Q1 2017.

  • Los Angeles Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Los Angeles Capital Management sold 49,930 Infinity Pharmaceuticals, Inc. shares in Q1 2017, an estimated $67K.
  • Los Angeles Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2016 and held it in 3 quarters.
  • Los Angeles Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $78K in Q3 2016.
  • 80 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2017.

Based on Los Angeles Capital Management's 13F filing for Q1 2017, filed 10 May 2017.